Azelis Group N.v. · EURONEXT:AZE
Azelis — Q3 2023 Earnings Presentation
14 slides from Azelis's earnings presentation, Nov 16, 2023
Slide 1: 9M 2023 Update
9M 2023 Update November 2023 Innovation through formulation
Slide 2: Agenda
Agenda 1• Key developments & business update 2• Financial performance 3• Outlook 4• Q&A 2 © 2023 Azelis group. All rights reserved
Slide 3: Disclaimer
Disclaimer This document may contain statement relevant to Azelis Group NV (the “Company”) and/or its affiliated companies (collectively “Azelis” or the “Azelis Group”) which are not historical facts and are hereby identified as “forward-looking statements”. Such forward looking statements, include,
Slide 4: Key developments & business update 9M 2023
Key developments & business update 9M 2023 4 © 2023 Azelis group. All rights reserved
Slide 5: Key developments 9M 2023
Key developments 9M 2023 Volatile markets Resilient margins Progress on initiatives Defensive Balance Sheet • 2.3% total revenue • 3.3% increase in gross • Continued investments • 41.5% increase in Free growth (6.3% in constant profit (7.1% in CC) to strengthen Azelis’ Cash Flow (€ 389.4m), currency
Slide 6: Business update: Industry recalibration
Business update: Industry recalibration Organic growth: Demand slowdown • Life Sciences: EMEA supported by stable trends in Food & Nutrition, strong performance in Pharma; Flavors & Fragrance stabilization in the US; sustained growth across end-markets in APAC; • Industrial Chemicals: Softer trends
Slide 7: Financial performance 9M 2023
Financial performance 9M 2023 7 © 2023 Azelis group. All rights reserved
Slide 8: Headline P&L 9M 2023
Headline P&L 9M 2023 Azelis Group Highlights Reported Reported Constant Q3 2023 Q3 2022 9M 2023 9M 2022 (EUR m) Change Change Currency Life Sciences 648.5 652.1 -0.6% 1,965.4 1,860.8 5.6% 9.5% Industrial Chemicals 389.8 436.6 -10.7% 1,214.2 1,246.9 -2.6% 1.4% Group Revenue 1,038.3 1,088.7 -4.6% 3,17
Slide 9: Headline growth 9M 2023
Headline growth 9M 2023 Azelis Performance F/X M&A Growth Organic Total 9M 2023 9M 2022 (EUR m) Translation Contribution Growth Growth EMEA 1,378.7 1,371.0 -4.6% 7.4% -2.2% 0.6% Americas 1,115.6 1,198.9 -2.2% 8.7% -13.4% -6.9% Asia Pacific 685.3 537.8 -6.1% 31.1% 2.4% 27.4% Group Revenue 3,179.6 3,1
Slide 10: Regional financial update
Regional financial update EMEA Americas Asia Pacific 14.2% EBITA EBITA 12.5% +0.6% 14.1% margin margin 13.1% € 1.379 -6.9% € 1.371 € 1.199 EBITA 8.7% 8.0% margin € 1.116 +27.4% Revenue € 685 Revenue Revenue € 538 9M 2022 9M 2023 9M 2022 9M 2023 9M 2022 9M 2023 Conversion Conversion 56,0% 55,9% Conve
Slide 11: Working Capital
Working Capital Working Capital Evolution of NWC* Receivables Inventory Payables NWC/ 10.9% 11.1% 15.3% 13.8% 15.9% 15.3% Revenue 653 603 628 467 262 268 443 531 517 376 200 218 -227 -235 -369 -463 -494 -455 2019 2020 2021 2022 9M 2022 9M 2023 DSO 34 35 44 37 45 43 Jan Feb Mar Apr May Jun Jul Aug Se
Slide 12: Outlook
Outlook 12 © 2023 Azelis group. All rights reserved
Slide 13: Outlook
Outlook Azelis' strategy of driving growth is underpinned by a continually strengthening lateral value chain, supported by continuous investments in innovation capabilities and digitalization, as well as a commitment to sustainability to create long-term value. In line with this, the management aims
Slide 14: 9M 2023 Update Q&A
9M 2023 Update Q&A Contact Investor Relations investor-relations@azelis.com +32 (0) 478 51 23 89 14 © 2023 Azelis group. All rights reserved